文献速递头颈外科

转移性头颈部腺样囊性癌的生存与预后

Survival and prognosis of metastatic head and neck adenoid cystic carcinoma.
PubMed 文献 · Head Neck · 2022-07-13

该研究回顾性分析1999年至2020年中国国家癌症中心174例转移性头颈部腺样囊性癌患者的临床资料,中位总生存期为45.6个月。单因素分析显示吸烟史、无病间期、转移数目和部位及全身治疗与总生存期相关;多因素分析中不吸烟、无病间期≥3年及肺转移为预后因素。局部治疗对转移灶未提供生存获益,但对局部病灶的局部治疗可能延长生存。

要点

  • 不吸烟、无病间期≥3年及肺转移为转移性头颈部腺样囊性癌的有利预后因素。
  • 对转移灶的局部治疗未提供生存获益,但对局部病灶的局部治疗可能延长生存。
  • 初始全身治疗能否改善预后需进一步探索。

核心结论

  • 不吸烟史、无病间期≥3年及肺转移为有利预后因素。
  • 对转移灶的局部治疗未提供生存获益,但对局部病灶的局部治疗可能延长生存。
  • 初始全身治疗能否改善预后需进一步探索。

研究设计与样本

  • 回顾性收集1999年至2020年中国国家癌症中心转移性头颈部腺样囊性癌患者的临床数据。
  • 共纳入174例转移性头颈部腺样囊性癌患者。

主要发现

  • 174例患者的中位总生存期为45.6个月。
  • 单因素分析显示吸烟史、无病间期、转移数目和部位及全身治疗与总生存期相关。
  • 多因素分析显示不吸烟、无病间期≥3年及肺转移为预后因素。
  • 对局部病灶的局部治疗可延长复发和转移患者的生存。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To investigate the clinical characteristics, treatment, and prognosis of patients with metastatic head and neck adenoid cystic carcinoma (HNACC). METHOD: The clinical data of metastatic HNACC from 1999 to 2020 at the National Cancer Center of China were retrospectively collected. RESULTS: One hundred seventy-four patients with metastatic HNACC were enrolled and median overall survival (OS) was 45.6 months. Univariate analysis indicated that smoking history, disease-free interval (DFI), number and sites of metastases, and systemic therapy were associated with OS. In the multivariate analysis, non-smokers, DFI ≥3 years, and lung metastasis were prognostic factors. Local therapy for localized disease could prolong survival in patients with both recurrent and metastatic disease. CONCLUSION: No smoking history, DFI ≥3 years, and lung metastasis were favorable prognostic factors. Local therapy for metastases could not provide survival benefits, but local therapy for localized disease may prolong survival. Whether initial systemic therapy could improve prognosis needs further exploration.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Zhang D, Chai Y, Wei Y, et al. Survival and prognosis of metastatic head and neck adenoid cystic carcinoma. Head Neck. 2022. PMID: 35822446. doi:10.1002/hed.27143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。